HBI-8000 in combination with nivolumab clinical trials

Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma

This study looks at a new drug, HBI-8000, combined with another treatment, nivolumab, for advanced skin cancer (melanoma) that has spread or can't be removed. It compares this combination to nivolumab alone, in adults and some teenagers.